This site is intended for healthcare professionals
Drug news

BMS announces CheckMate -227 Part 1aevaluating Opdivo + low-dose Yervoy meets co-primary endpoint of overall survival in first-line NSCLC

Read time: 1 mins
Last updated:30th Jul 2019
Published:26th Jul 2019
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest